These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1423879)

  • 21. K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid.
    Narahara H; Tatsuta M; Iishi H; Baba M; Uedo N; Sakai N; Yano H; Ishiguro S
    Int J Cancer; 2000 Oct; 88(2):157-61. PubMed ID: 11004662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.
    Paulsen JE; Bjørheim J; Røe J; Eide TJ; Alexander J; Gaudernack G
    Anticancer Res; 2002; 22(1A):171-5. PubMed ID: 12017282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
    Whiteley LO; Hudson L; Pretlow TP
    Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats.
    De Filippo C; Caderni G; Bazzicalupo M; Briani C; Giannini A; Fazi M; Dolara P
    Br J Cancer; 1998 Jun; 77(12):2148-51. PubMed ID: 9649126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity.
    Pretlow TP; Cheyer C; O'Riordan MA
    Int J Cancer; 1994 Feb; 56(4):599-602. PubMed ID: 8112897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study.
    Marotta F; Naito Y; Minelli E; Tajiri H; Bertuccelli J; Wu CC; Min CH; Hotten P; Fesce E
    Hepatogastroenterology; 2003; 50(54):1914-8. PubMed ID: 14696432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine.
    Femia AP; Tarquini E; Salvadori M; Ferri S; Giannini A; Dolara P; Caderni G
    Int J Cancer; 2008 Jan; 122(1):117-23. PubMed ID: 17847023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods.
    Tudek B; Bird RP; Bruce WR
    Cancer Res; 1989 Mar; 49(5):1236-40. PubMed ID: 2917353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
    Magnuson BA; Carr I; Bird RP
    Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
    Yuan P; Sun M; Zhang J; Zhu X; Shi D
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats.
    Zhang Y; Li Q; Zhou D; Chen H
    Br J Nutr; 2013 Jan; 109(1):33-42. PubMed ID: 22716201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane.
    Lau DS; Archer MC
    Int J Cancer; 2009 Jun; 124(11):2750-3. PubMed ID: 19173288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis?
    Pretlow TP
    Gastroenterology; 1995 Feb; 108(2):600-3. PubMed ID: 7835604
    [No Abstract]   [Full Text] [Related]  

  • 38. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
    Smith AJ; Stern HS; Penner M; Hay K; Mitri A; Bapat BV; Gallinger S
    Cancer Res; 1994 Nov; 54(21):5527-30. PubMed ID: 7923190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
    Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.
    Pattananandecha T; Sirilun S; Duangjitcharoen Y; Sivamaruthi BS; Suwannalert P; Peerajan S; Chaiyasut C
    Pharm Biol; 2016 Sep; 54(9):1596-605. PubMed ID: 26794346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.